Syndrome Arrays from Randox offer Simultaneous Patient Profiling with Randox Metabolic Syndrome Arrays
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
The Metabolic determination of analytes associated with Metabolic Syndrome and related disorders for improved patient profiling.
Metabolic Syndrome Array I includes these analytes; C-peptide, Ferritin, IL-1a, IL- 6, Insulin, Leptin, Plasminogen Activator Inhibitor-I, Resistin and Tumour Necrosis Factor a. Metabolic Syndrome Array II includes; Adiponectin, CRP and Cystatin C. Utilizing multiplexing Biochip technology, these arrays can provide cost and time savings as multiple assays can be run on one sample, according to Randox.
The Metabolic Syndrome Arrays are suitable for use on plasma and serum, using only 100 µl of sample to measure all analytes on each array. Randox also offer a complete range of multi- analyte controls and calibrators to ensure reliable results.
Metabolic Syndrome Array I includes these analytes; C-peptide, Ferritin, IL-1a, IL- 6, Insulin, Leptin, Plasminogen Activator Inhibitor-I, Resistin and Tumour Necrosis Factor a. Metabolic Syndrome Array II includes; Adiponectin, CRP and Cystatin C. Utilizing multiplexing Biochip technology, these arrays can provide cost and time savings as multiple assays can be run on one sample, according to Randox.
The Metabolic Syndrome Arrays are suitable for use on plasma and serum, using only 100 µl of sample to measure all analytes on each array. Randox also offer a complete range of multi- analyte controls and calibrators to ensure reliable results.
